Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection
- PMID: 22018491
- PMCID: PMC6487494
- DOI: 10.1016/j.virol.2011.09.023
Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection
Abstract
Rift Valley fever virus (RVFV) causes significant morbidity and mortality in humans and livestock throughout Africa and the Middle East. The clinical disease ranges from mild febrile illness, to hepatitis, retinitis, encephalitis and fatal hemorrhagic fever. RVFV NSs protein has previously been shown to interfere in vitro with the interferon response, and RVFV lacking the NSs protein is attenuated in several animal models. Monocytes and macrophages are key players in the innate immune response via expression of various cytokines and chemokines. Here we demonstrate that wild-type RVFV infection of human monocyte-derived macrophages leads to a productive infection and inhibition of the innate immune response via decreased expression of IFN-α2, IFN-β and TNF-α. Using a recombinant virus lacking the NSs protein, we show that this effect is mediated by the viral NSs protein. Finally, analysis of RVF patient samples demonstrated an association between a pro-inflammatory cytokine response and patient survival.
Published by Elsevier Inc.
Figures





Similar articles
-
Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.J Virol. 2013 Jun;87(11):6161-71. doi: 10.1128/JVI.00337-13. Epub 2013 Mar 27. J Virol. 2013. PMID: 23536675 Free PMC article.
-
The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.J Virol. 2020 Dec 9;95(1):e01768-20. doi: 10.1128/JVI.01768-20. Print 2020 Dec 9. J Virol. 2020. PMID: 33087469 Free PMC article.
-
Rift Valley Fever Virus Propagates in Human Villous Trophoblast Cell Lines and Induces Cytokine mRNA Responses Known to Provoke Miscarriage.Viruses. 2021 Nov 12;13(11):2265. doi: 10.3390/v13112265. Viruses. 2021. PMID: 34835071 Free PMC article.
-
Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.Virus Res. 2016 May 2;216:55-65. doi: 10.1016/j.virusres.2015.05.012. Epub 2015 May 27. Virus Res. 2016. PMID: 26022573 Free PMC article. Review.
-
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins.Virol J. 2016 Jul 2;13:118. doi: 10.1186/s12985-016-0573-8. Virol J. 2016. PMID: 27368371 Free PMC article. Review.
Cited by
-
Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo Hemorrhagic Fever Virus.PLoS Negl Trop Dis. 2020 Apr 6;14(4):e0008105. doi: 10.1371/journal.pntd.0008105. eCollection 2020 Apr. PLoS Negl Trop Dis. 2020. PMID: 32251473 Free PMC article.
-
The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages.Emerg Microbes Infect. 2017 Jan 18;6(1):e4. doi: 10.1038/emi.2016.136. Emerg Microbes Infect. 2017. PMID: 28096531 Free PMC article.
-
Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.J Virol. 2018 Jan 17;92(3):e01662-17. doi: 10.1128/JVI.01662-17. Print 2018 Feb 1. J Virol. 2018. PMID: 29118127 Free PMC article.
-
Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.J Gen Virol. 2015 Jul;96(Pt 7):1651-1663. doi: 10.1099/vir.0.000119. Epub 2015 Mar 10. J Gen Virol. 2015. PMID: 25759029 Free PMC article.
-
Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.J Virol. 2013 Jun;87(11):6161-71. doi: 10.1128/JVI.00337-13. Epub 2013 Mar 27. J Virol. 2013. PMID: 23536675 Free PMC article.
References
-
- Anderson GW Jr., Slone TW Jr., Peters CJ, 1987. Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. Microb. Pathog 2, 283–293. - PubMed
-
- Anderson GW Jr., Lee JO, Anderson AO, Powell N, Mangiafico JA, Meadors G, 1991. Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats. Vaccine 9, 710–714. - PubMed
-
- Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, Deubel V, 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol 172, 2861–2869. - PubMed
-
- Baize S, Pannetier D, Faure C, Marianneau P, Marendat I, Georges-Courbot MC, Deubel V, 2006. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect. 8,1194–1202. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources